Frontier Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $21.9M | Sell |
|
|||||
|
2023
Q2 | $35.1M | Buy |
|
|||||
|
2023
Q1 | $18.4M | Buy |
|
|||||
|
2022
Q4 | $15.7M | Sell |
|
|||||
|
2022
Q3 | $18M | Sell |
|
|||||
|
2022
Q2 | $21.7M | Sell |
|
|||||
|
2022
Q1 | $29.9M | Sell |
|
|||||
|
2021
Q4 | $38.1M | Sell |
|
|||||
|
2021
Q3 | $38.3M | Sell |
|
|||||
|
2021
Q2 | $37.8M | Buy |
|
|||||
|
2021
Q1 | $23.4M | Sell |
|
|||||
|
2020
Q4 | $30.8M | Sell |
|
|||||
|
2020
Q3 | $42.1M | Sell |
|
|||||
|
2020
Q2 | $46.8M | Sell |
|
|||||
|
2020
Q1 | $45.3M | Sell |
|
|||||
|
2019
Q4 | $69.1M | Sell |
|
|||||
|
2019
Q3 | $73.1M | Sell |
|
|||||
|
2019
Q2 | $119M | Sell |
|
|||||
|
2019
Q1 | $137M | Sell |
|
|||||
|
2018
Q4 | $113M | Sell |
|
|||||
|
2018
Q3 | $139M | Buy |
|
|||||
|
2018
Q2 | $111M | Sell |
|
|||||
|
2018
Q1 | $109M | Buy |
|
|||||
|
2017
Q4 | $86.8M | Sell |
|
|||||
|
2017
Q3 | $87.7M | Buy |
|
|||||
|
2017
Q2 | $94.6M | Sell |
|
|||||
|
2017
Q1 | $75.7M | Sell |
|
|||||
|
2016
Q4 | $78.8M | Buy |
|
|||||
|
2016
Q3 | $101M | Buy |
|
|||||
|
2016
Q2 | $60.9M | Buy |
|
|||||
|
2016
Q1 | $26.7M | Buy |
|
|||||
|
2015
Q4 | $23.1M | Sell |
|
|||||
|
2015
Q3 | $20.8M | Buy |
|
|||||
|
2015
Q2 | $20.9M | Buy |
|
|||||
|
2015
Q1 | $20.8M | Sell |
|
|||||
|
2014
Q4 | $19.3M | Sell |
|
|||||
|
2014
Q3 | $16M | Sell |
|
|||||
|
2014
Q2 | $13.6M | Sell |
|
|||||
|
2014
Q1 | $12.4M | Buy |
|
|||||
|
2013
Q4 | $9.3M | Sell |
|
|||||
|
2013
Q3 | $33.3M | Sell |
|
|||||
|
2013
Q2 | $39.2M | Buy |
|